NEW YORK--(BUSINESS WIRE)---- $KBR #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against KBR, Inc. ("KBR†or the "Company†) (NYSE: KBR) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recover ...

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Texas on behalf of all persons or entities who purchased or otherwise acquired KBR, Inc. (“KBR” or the “Company”) (NYSE: KBR) securities between May 6, 2025 and June 19, 2025, inclusive (the “Class Period”). The Complaint alleges that throughout the Class Period Defendants made false and/or misleading statement ...

Group 1 - A shareholder class action lawsuit has been filed against KBR, Inc. alleging that the company made materially false and misleading statements regarding its business operations and prospects [1] - The lawsuit claims that KBR misrepresented the status of its partnership with the U.S. Department of Defense's Transportation Command (TRANSCOM), despite known concerns about HomeSafe's ability to fulfill the Global Household Goods Contract [1] - The period for affected shareholders to seek legal recourse is from May 6, 2025, to June 19, 2025, with a deadline to be appointed lead plaintiff by November 18, 2025 [2] Group 2 - Holzer & Holzer, LLC is representing the shareholders in this litigation and has a history of recovering significant amounts for investors affected by corporate misconduct [2] - The firm has been recognized as an ISS top-rated securities litigation law firm for the years 2021, 2022, and 2023 [2] - Holzer & Holzer, LLC has been active in shareholder class action and derivative litigation since its founding in 2000 [2]

SAN FRANCISCO , Sept. 22, 2025 /PRNewswire/ -- A new class-action lawsuit is targeting KBR, Inc. (NYSE: KBR), alleging the company made misleading statements to investors in the weeks leading up to the abrupt cancellation of a major military contract. ...

Group 1 - KBR, Inc. investors have the opportunity to lead a securities fraud lawsuit with the Schall Law Firm [1] - The lawsuit is focused on allegations of securities fraud against KBR, Inc. [1] - The involvement of the Schall Law Firm indicates a potential collective action by investors [1] Group 2 - The announcement highlights the legal challenges faced by KBR, Inc. in relation to investor claims [1] - The situation may impact KBR's reputation and investor confidence moving forward [1] - The outcome of the lawsuit could have financial implications for KBR, Inc. [1]

NEW YORK , Sept. 20, 2025 /PRNewswire/ -- Why:Â Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the "Class Period"). ...

Core Viewpoint - A class action lawsuit has been filed against Jasper Therapeutics, Inc. for allegedly misleading investors regarding the commercial prospects of its lead product candidate, briquilimab [1][2]. Group 1: Allegations - The lawsuit claims that Jasper Therapeutics failed to disclose critical information about its manufacturing controls and procedures, which were necessary to ensure compliance with cGMP regulations [2]. - The lack of proper controls increased the risk of confounding results in ongoing studies, negatively impacting the regulatory and commercial prospects of the company's products, including briquilimab [2]. - This situation heightened the likelihood of disruptive cost-reduction measures, leading to an overstatement of the company's business and financial prospects [2]. Group 2: Stock Price Impact - Following the revelation of these issues on July 7, 2025, Jasper's stock price plummeted by $3.73 per share, representing a 55.1% decline, closing at $3.04 per share [3]. Group 3: Class Action Participation - Shareholders who purchased Jasper Therapeutics securities between November 30, 2023, and July 3, 2025, may be eligible to participate in the class action [1][4]. - Interested shareholders can contact Robbins LLP to serve as lead plaintiff or remain as absent class members without participating in the case [4].

Core Viewpoint - Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit for purchasers or acquirers of KBR, Inc. securities during a specified period [1] Group 1 - The class period for the KBR, Inc. lawsuit is defined as between May 6, 2025, and June 19, 2025 [1] - Interested parties have until November 18, 2025, to seek appointment as lead plaintiff in the lawsuit [1]

Group 1 - A class action has been filed against KBR, Inc. on behalf of investors who acquired its securities between May 6, 2025, and June 19, 2025 [1] - The allegations center around KBR's joint venture, HomeSafe Alliance, which has a 72% economic interest from KBR and was awarded a contract by the U.S. Department of Defense's TRANSCOM [2] - It is claimed that KBR misled investors about HomeSafe's ability to fulfill the Global Household Goods Contract, despite knowing of TRANSCOM's concerns [3] Group 2 - On June 19, 2025, HomeSafe announced a notice to terminate the Global Household Goods Contract, revealing ongoing issues with TRANSCOM [4] - Following the announcement, KBR's stock price dropped by $3.85 (7.29%) to close at $48.93 on June 20, 2025, and further fell by $1.30 (2.65%) to close at $47.63 on June 23, 2025 [4] - Shareholders interested in leading the class action must submit their papers by November 18, 2025, and can remain absent class members if they choose not to participate [5]

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of KBR, Inc. securities purchasers during the specified Class Period, alleging that the company made materially false and misleading statements regarding its business operations and prospects [1][5]. Group 1: Lawsuit Details - The class action lawsuit pertains to KBR, Inc. securities purchased between May 6, 2025, and June 19, 2025 [1]. - The lawsuit claims that KBR's management misrepresented the status of its partnership with the U.S. Department of Defense's Transportation Command, despite known concerns about HomeSafe's ability to fulfill contractual obligations [5]. - Investors are encouraged to join the class action without incurring out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by November 18, 2025, to represent the class in the litigation [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].